Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS BPC 157: What Research Shows (and What It Doesn't) Meeting Point Health Peptides for Plastic Surgery Recovery: A Clinical Guide to GLOW, KLOW, and NAD Plus Frank Agullo, MD